Wednesday, June 10, 2026

pharma Β· RSV Infection Β· NASH - Nonalcoholic Steatohepatitis Β· ENTA

ENANTA PHARMACEUTICALS

ENANTA PHARMACEUTICALS trial registry β€” 46 ClinicalTrials.gov studies with program phase, status, and indication context.

4 Kingsbury Ave, Watertown, Massachusetts 02472, US HQ
1995 Founded
145 Employees
Public company Type
ENTA Β· NYSE Ticker
Company details
Status
Public
HQ
4 Kingsbury Ave, Watertown, Massachusetts 02472, US
Founded
1995
Employees
145
Programs
34
Drugs
15
Patents
218
Intelligence Β· Clinical Trials

ENANTA PHARMACEUTICALS clinical trials

Registry index of 46 ClinicalTrials.gov studies linked to ENANTA PHARMACEUTICALS programs β€” each row shows trial ID, program name, phase, status, and indication.

ENANTA PHARMACEUTICALS trial registry β€” 46 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for ENANTA PHARMACEUTICALS.

  1. Fluconazole β€” Phase 1

    Clinical update
  2. EDP-305 Dose 1 β€” Phase 2

    Clinical update
  3. EDP-938 β€” Phase 2

    Clinical update
  4. EDP-514 β€” Phase 1

    Clinical update
  5. EDP-235 β€” Phase 2

    Clinical update
  6. EDP-938, EDP-938 Placebo tablets β€” Phase 2

    Clinical update
  7. zelicapavir (therapeutic dose) β€” Phase 1

    Clinical update
  8. intraconazole β€” Phase 1

    Clinical update

Trial registry

46 studies